Healthcare -
Medical - Care Facilities - NASDAQ - US
$ 25.28
2.56 %
$ 1.26 B
Market Cap
34.63
P/E
1. INTRINSIC VALUE
Balance Sheet
Astrana Health, Inc.
| Current Assets | 638 M |
| Cash & Short-Term Investments | 291 M |
| Receivables | 325 M |
| Other Current Assets | 22.9 M |
| Non-Current Assets | 716 M |
| Long-Term Investments | 100 M |
| PP&E | 46.9 M |
| Other Non-Current Assets | 569 M |
| Current Liabilities | 223 M |
| Accounts Payable | 15.2 M |
| Short-Term Debt | 15.3 M |
| Other Current Liabilities | 192 M |
| Non-Current Liabilities | 475 M |
| Long-Term Debt | 457 M |
| Other Non-Current Liabilities | 18.6 M |
EFFICIENCY
Earnings Waterfall
Astrana Health, Inc.
| Revenue | 2.03 B |
| Cost Of Revenue | 1.76 B |
| Gross Profit | 271 M |
| Operating Expenses | 182 M |
| Operating Income | 89.4 M |
| Other Expenses | 39.4 M |
| Net Income | 49.9 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Astrana Health, Inc.
| Net Income | 49.9 M |
| Depreciation & Amortization | 27.9 M |
| Capital Expenditures | -8.03 M |
| Stock-Based Compensation | 34.5 M |
| Change in Working Capital | -63.6 M |
| Others | -14.4 M |
| Free Cash Flow | 44.2 M |
Wall Street Analysts Price Targets
Astrana Health, Inc.
Wall Street analysts predict an average 1-year price target for ASTH of $55.8 , with forecasts ranging from
a
low of
$36 to a high of $70 .
ASTH Lowest Price Target
Wall Street Target
36 USD
42.41%
ASTH Average Price Target
Wall Street Target
55.8 USD
120.53%
ASTH Highest Price Target
Wall Street Target
70 USD
176.90%
4. DIVIDEND
ANALYSIS
ASTH does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Astrana Health, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Astrana Health Announces Closing of Prospect Health Acquisition
ALHAMBRA, Calif. , July 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it closed the acquisition of Prospect Health on July 1st, 2025.
prnewswire.com
- 6 days ago
New Strong Sell Stocks for June 4th
ASLE, ASTH and MITT have been added to the Zacks Rank #5 (Strong Sell) List on May 4 2025.
zacks.com
- 1 month ago
Astrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for All
ALHAMBRA, Calif. , June 3, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced several key additions to its senior leadership team.
prnewswire.com
- 1 month ago
Astrana Health, Inc. to Participate in Upcoming Investor Conference
ALHAMBRA, Calif. , June 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO is participating in the William Blair 2025 Growth Stock Conference, being held in Chicago, from Tuesday, June 3, 2025 to Thursday June 5, 2025 including a presentation at 10:40 am CT on Wednesday, June 4.
prnewswire.com
- 1 month ago
Astrana Health, Inc. (ASTH) Q1 2025 Earnings Call Transcript
Astrana Health, Inc. (NASDAQ:ASTH ) Q1 2025 Earnings Conference Call May 8, 2025 5:30 PM ET Company Participants Brandon Sim - President & Chief Executive Officer Chan Basho - Chief Operating & Financial Officer. Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Jack Slevin - Jefferies Jailendra Singh - Truist Securities Ryan Langston - TD Cowen Brooks O'Neil - Lake Street Capital Markets David Larsen - BTIG Gene Mannheimer - Freedom Capital Markets Thomas Walsh - Barclays Operator Good day, everyone, and welcome to today's Astrana's Health First Quarter 2025 Earnings Call.
seekingalpha.com
- 1 month ago
Astrana Health, Inc. (ASTH) Q1 Earnings and Revenues Lag Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.31 per share a year ago.
zacks.com
- 1 month ago
Astrana Health, Inc. Reports First Quarter 2025 Results
Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m.
prnewswire.com
- 1 month ago
Astrana Health, Inc. (ASTH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Astrana Health, Inc. (ASTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com
- 2 months ago
Astrana Health, Inc. to Participate in Upcoming Investor Conference
ALHAMBRA, Calif. , April 24, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO, and Chan Basho, CFO and COO, are participating in the BofA Securities 2025 Health Care Conference, being held in Las Vegas, on Tuesday, May 13, 2025, including a fireside chat at 3:00pm PT.
prnewswire.com
- 2 months ago
Astrana Health, Inc. (ASTH) Q4 2024 Earnings Call Transcript
Astrana Health, Inc. (NASDAQ:ASTH ) Q4 2024 Earnings Conference Call February 27, 2025 5:30 PM ET Company Participants Brandon Sim - President & CEO Chan Basho - Chief Operating & Financial Officer Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Jailendra Singh - Truist Securities Ryan Langston - TD Cowen Adam Ron - Bank of America Craig Jones – Stifel Brooks O'Neil - Lake Street Capital David Larsen - BTIG Matt Gilmore - KeyBanc Capital Gene Mannheimer - Freedom Capital Markets Operator Good day, everyone, and welcome to today's Astrana Health Fourth Quarter and Full Year 2024 Earnings Call. [Operator Instructions] Later, you will have the opportunity to ask questions during the question-and-answer session.
seekingalpha.com
- 4 months ago
Astrana Health, Inc. (ASTH) Reports Q4 Loss, Tops Revenue Estimates
Astrana Health, Inc. (ASTH) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.26 per share a year ago.
zacks.com
- 4 months ago
Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results
Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m.
prnewswire.com
- 4 months ago
8. Profile
Summary
Astrana Health, Inc. ASTH
COUNTRY
US
INDUSTRY
Medical - Care Facilities
MARKET CAP
$ 1.26 B
Dividend Yield
0.00%
Description
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Contact
1668 S. Garfield Avenue, Alhambra, CA, 91801
https://www.astranahealth.com
IPO
Date
March 11, 2009
Employees
1900
Officers
Mr. Brandon K. Sim M.S.
President & Chief Executive Officer
Ms. Rita Pew M.B.A.
Chief People Officer
Dr. Jeremy R. Jackson M.D.
Chief Quality Officer
Mr. Neil Ahuja
President of Provider Solutions
Mr. Chandan Basho M.B.A.
Chief Financial Officer, Chief Operating Officer & Corporate Secretary
Dr. Dinesh M. Kumar M.D.
Chief Medical Officer
Dr. Kenneth T. Sim M.D.
Co-Founder & Executive Chairman
Dr. Thomas S. Lam M.D., M.P.H.
Co-Founder & Vice Chairman
Dr. WaiChow Young M.D., M.P.H.
Senior Vice President of Health Affairs
Mr. Glenn W. Sobotka
Chief Accounting Officer & Principal Accounting Officer